Sais e Derivados de API
Os sais dos Ingredientes Farmacêuticos Ativos (API) são compostos formados pela reação de um ácido com uma base, resultando em um equilíbrio iônico. Esses sais frequentemente melhoram a solubilidade e a estabilidade dos APIs, facilitando sua absorção no organismo. Os derivados de API são variantes químicas de um princípio ativo que podem apresentar propriedades aprimoradas ou modificadas para otimizar a eficácia terapêutica. Os sais de APIs são utilizados na formulação de medicamentos orais, injetáveis e tópicos. Além disso, os derivados de API podem melhorar a farmacocinética dos fármacos, permitindo, por exemplo, a liberação controlada de substâncias ativas.
Na CymitQuimica, oferecemos sais e derivados de APIs com a pureza e qualidade necessárias para pesquisa e desenvolvimento de formulações farmacêuticas.
Foram encontrados 79383 produtos de "Sais e Derivados de API"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Triethylamine
CAS:Acyclic monoamines and their derivatives, nesoiFórmula:C6H15NCor e Forma:Clear Colorless LiquidPeso molecular:101.12045Amlodipine Related Compound B (3-Ethyl 5-methyl 4-(2-chlorophenyl)-6-methyl-2-({2-[2-(methylcarbamoyl)benzamido]ethoxy}methyl)-1,4-dihydropyridine-3,5-dicarboxylate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C29H32ClN3O7Cor e Forma:White PowderPeso molecular:569.19288Buspirone Related Compound N (8,8'-(Butane-1,4-diyl)bis(8-azaspiro[4.5]decane-7,9-dione)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C22H32N2O4Cor e Forma:White SolidPeso molecular:388.23621Metaxalone Related Compound B (1-amino-3-(3,5-dimethylphenoxy)propan-2-ol)
CAS:Aromatic monoamines not elsewhere specified or included and their derivatives, salts therofFórmula:C11H17NO2Cor e Forma:White PowderPeso molecular:195.12593Phenylbutyrate Related Compound C (4-cyclohexylbutanoic acid)
CAS:Cyclanic, cyclenic or cycloterpenic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivativesFórmula:C10H18O2Cor e Forma:White PowderPeso molecular:170.13068Apixaban Related Compound G (Ethyl 6-[4-(5-bromopentanamido)phenyl]-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate)
CAS:Lactams, nesoiFórmula:C27H29BrN4O5Cor e Forma:Cream PowderPeso molecular:568.13213Proguanil Related Compound F (1-(3,4-Dichlorophenyl)-5-isopropylbiguanide hydrochloride)
CAS:Aromatic imines and their derivatives, salts thereofFórmula:C11H15Cl2N5·HCICor e Forma:White Crystalline PowderPeso molecular:426.98275Amoxicillin Related Compound I ((R)-2-Amino-2-(4-hydroxyphenyl)acetic acid)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFórmula:C8H9NO3Cor e Forma:White Crystalline PowderPeso molecular:167.058245-Methylisoxazole-4-carboxylic Acid (5-Methyl-1,2-oxazole-4-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C5H5NO3Cor e Forma:White SolidPeso molecular:127.02694Amoxicillin Related Compound C ((4S)-2-[5-(4-hydroxyphenyl)-3,6-dioxopiperazin-2-yl]-5,5-dimethylthiazolidine-4-carboxylic acid)
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFórmula:C16H19N3O5SCor e Forma:White PowderPeso molecular:365.10454Nebivolol Related Compound C ((RS)-6-Fluoro-2-[(RS)-oxiran-2-yl]chroman)
CAS:Aromatic pesticides with oxygen heteroFórmula:C11H11FO2Cor e Forma:Liquid Low-Melting SolidPeso molecular:194.07431Budesonide Related Compound G (16α,17-[butylidenebis(oxy)]-11β, 21-dihydroxypregna-4-ene-3,20-dione)
CAS:Adrenal cortical hormones and their derivatives nesoiFórmula:C25H36O6Cor e Forma:Off-White PowderPeso molecular:432.25119Efavirenz Related Compound A ((S)-2-(2-amino-5-chlorophenyl)-4-cyclopropyl-1,1,1-trifluorobut-3-yn-2-ol)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFórmula:C13H11NOF3ClCor e Forma:White PowderPeso molecular:289.04813Inamrinone Related Compound B (2-Hydroxy-N-(6-oxo-1,6-dihydro-[3,4'-bipyridin]-5-yl)propanamide)
Lactams not elsewhere specified or includedFórmula:C13H13N3O3Cor e Forma:Tan PowderPeso molecular:259.09569Haloperidol Related Compound A (4,4'-Bis[4-(p-chlorophenyl)-4-hydroxypiperidino]butyrophenone)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C32H36Cl2N2O3Cor e Forma:White PowderPeso molecular:566.2103Amitriptyline Related Compound A (dibenzosuberone)
CAS:Aromatic ketones without other oxygen function, nesoiFórmula:C15H12OCor e Forma:Pale Yellow PowderPeso molecular:208.08882Iopamidol Related Compound A (N,N'-Bis-(1,3-dihydroxy-2-propyl)-5-amino-2,4,6-triiodoisophthalamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C14H18I3N3O6Cor e Forma:White PowderPeso molecular:704.83298Phenylephrine Related Compound D ((R)-3-{2-[Benzyl(methyl)amino]-1-hydroxyethyl}phenol)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-pheFórmula:C16H19NO2Cor e Forma:White PowderPeso molecular:257.14158Loratadine Related Compound C (8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one)
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFórmula:C14H10ClNOCor e Forma:Light Yellow PowderPeso molecular:243.04509Dacarbazine Related Compound B (2-Azahypoxanthine monohydrate)
CAS:Heterocyclic compounds (excluding aromatic or modified aromatic) withnitrogen hetero-atom(s) only nesoiFórmula:C4H3N5OCor e Forma:Pink Orange PowderPeso molecular:137.03376Phenylephrine Related Compound G ((R)-N-(2-Hydroxy-2-(3-hydroxyphenyl)ethyl)-N-methylglycine)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-pheFórmula:C11H15NO4Cor e Forma:White PowderPeso molecular:225.10011Econazole Related Compound B (2-[(4-Chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethanamine nitrate)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFórmula:C15H14Cl3NO·HNO3Cor e Forma:White PowderPeso molecular:329.0141Dipyridamole Related Compound E (2,2',2'',2'''-{[6,8-Di(piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,4-diyl]bis(azanetriyl)}tetraethanol)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C24H40N8O4Cor e Forma:SolidPeso molecular:504.31725Fosinopril Related Compound D ((4R)-4-cyclohexyl-1-[(R)-[(S)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]acetyl-L-proline propionate (ester), sodium salt)
CAS:Aromatic or modified aromatic drugs with nitrogen heterFórmula:C30H45NNaO7PCor e Forma:White PowderPeso molecular:585.28313Clopidogrel Related Compound A ((+)-(S)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetic acid, hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C15H14ClNO2S·HClCor e Forma:Off-White PowderPeso molecular:307.04338Foscarnet Related Compound B (disodium (ethoxyoxidophosphanyl)formate)
Non-halogenated organo-phosphorous derivatives, nesoiFórmula:C3H5Na2O5PCor e Forma:White PowderPeso molecular:198.02Latanoprost Related Compound D (Isopropyl (Z)-7-{(1R,2R,3R,5S)-2-[(R)-5-phenyl-3-(triethylsilyloxy)pentyl]-3,5-bis(triethylsilyloxy)cyclopentyl}hept-5-enoate)
CAS:Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analoguesFórmula:C44H82O5Si3Cor e Forma:Yellow LiquidPeso molecular:774.54701Timolol Related Compound B (3-(tert-Butylamino)-2-(4-morpholino-1,2,5-thiadiazol-3-yloxy)propan-1-ol)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C13H24N4O3SCor e Forma:White Off-White PowderPeso molecular:316.15691Lacosamide Related Compound F (2-Acetamido-N-benzyl-3-hydroxypropanamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C12H16N2O3Cor e Forma:White PowderPeso molecular:236.11609Quetiapine Related Compound G (Dibenzo[b,f][1,4]thiazepin-11(10H)-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C13H9NOSCor e Forma:White Off-White PowderPeso molecular:227.04049Piroxicam Related Compound B (4-Hydroxy-N-(pyridin-2-yl)-2H-benzothiazine-3-carboxamide 1,1-dioxide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C14H11N3O4SCor e Forma:Green Yellow PowderPeso molecular:317.04703Repaglinide Related Compound B (3-Ethoxy-4-ethoxycarbonylphenylacetic acid)
CAS:Carboxylic acids with additional oxygen function and thFórmula:C13H16O5Cor e Forma:PowderPeso molecular:252.09977Benzphetamine Related Compound F ((1S,2S)-2-[Benzyl(methyl)amino]-1-cyclohexylpropan-1-ol hydrochloride)
CAS:Aromatic drugs of amino-alcohols, other than those contg > one kind of oxygen function, their ethers and esters; salts thereof, nesoiFórmula:C17H27NO·HClCor e Forma:White Off-White PowderPeso molecular:297.18594Cefadroxil Related Compound B ((6R,7R)-7-amino-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C8H10N2O3SCor e Forma:Off-White Crystalline PowderPeso molecular:214.04121Paclitaxel Related Compound A (Cephalomannine)
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFórmula:C45H53NO14Cor e Forma:White Off-White PowderPeso molecular:831.34661Cidofovir Enantiomer (1-[(R)-3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C8H14N3O6PCor e Forma:White Off-White PowderPeso molecular:279.06202Flunixin Related Compound C (Ethyl 2-chloronicotinate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C8H8ClNO2Cor e Forma:Clear LiquidPeso molecular:185.02436Metaraminol Enantiomer (3-[(1S,2R)-2-Amino-1-hydroxypropyl]phenol D-tartrate)
CAS:Other alkaloids,natural or reproduced by synthesis, and their salts, ethers,esters&other derivatives, nesoiFórmula:C9H13NO2C4H6O6Cor e Forma:Off-White SolidPeso molecular:167.09463Torsemide Related Compound C (N-[(ethylamino)carbonyl]-4-[(3-methylphenyl)amino]-3-pyridinesulfonamide)
CAS:Sulfonamides, excluding drugsFórmula:C15H18N4O3SCor e Forma:White Off-White PowderPeso molecular:334.10996Acetylcysteine Related Compound D (N,S-Diacetyl-L-Cysteine)
CAS:Other organo-sulfur acid compoundsFórmula:C7H11NO4SCor e Forma:White SolidPeso molecular:205.04088Hexyl Methanesulfonate
CAS:Hydrocarbon derivatives containing only sulfo groups, their salts andestersFórmula:C7H16O3SCor e Forma:Clear Yellow LiquidPeso molecular:180.08202Diazepam Related Compound B (3-Amino-6-chloro-1-methyl-4-phenylcarbostyril)
CAS:Lactams, nesoiFórmula:C16H13ClN2OCor e Forma:Pale Yellow PowderPeso molecular:284.07164Dipyridamole Related Compound D (2,2'-({6-[(2-Hydroxyethyl)amino]-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-2-yl}azanediyl)diethanol)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C22H36N8O3Cor e Forma:Yellow PowderPeso molecular:460.29104Felbamate Related Compound B (Phenethyl carbamate)
CAS:Aromatic cyclic amides (including cyclic carbamates) anFórmula:C9H11NO2Cor e Forma:White Crystalline PowderPeso molecular:165.07898Tetrahydrozoline Related Compound E (N-(2-Aminoethyl)-1,2,3,4-tetrahydronaphthalene-1-carboxamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C13H18N2OCor e Forma:White SolidPeso molecular:218.14191Vinorelbine Related Compound A (4-O-Deacetylvinorelbine tartrate)
CAS:Other alkaloids,natural or reproduced by synthesis, and their salts, ethers,esters&other derivatives, nesoiFórmula:C43H52N4O7·2C4H6O6Cor e Forma:Light Yellow Off-White PowderPeso molecular:736.3836Daunorubicinone ((8S,10S)-8-Acetyl-6,8,10,11-tetrahydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione)
CAS:Ketone-phenols and ketones with other oxygen functionFórmula:C21H18O8Cor e Forma:Orange Red PowderPeso molecular:398.10017Anagrelide Related Compound B ((2-amino-5,6-dichloroquinazolin-3(4H)-yl)acetic acid)
Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C10H9Cl2N3O2·HClCor e Forma:Off-White PowderPeso molecular:273.00718Timolol Related Compound F (3-Chloro-4-morpholino-1,2,5-thiadiazol)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C6H8ClN3OSCor e Forma:Off-White PowderPeso molecular:205.00766Perphenazine Related Compound B (2-{4-[3-(10H-phenothiazin-10-yl)propyl]piperazin-1-yl}ethanol)
CAS:Compounds (excluding drugs) containing a phenothiazine ring-system (whether or not hydrogenated), not further fusedFórmula:C21H27N3OSCor e Forma:Off-White PowderPeso molecular:369.18748Milnacipran Related Compound C ((1RS ,2SR)-2-[(1,3-Dioxoisoindolin-2-yl)methyl]-N,N-diethyl-1-phenylcyclopropane-1-carboxamide)
CAS:Imides and their derivatives (excluding sacharin), salt thereofFórmula:C23H24N2O3Cor e Forma:SolidPeso molecular:376.17869Lovastatin Related Compound A (4,4a-Dihydrolovastatin)
Aromatic or modified aromatic drugs with nitrogen heteroFórmula:C24H38O5Cor e Forma:White Crystalline PowderPeso molecular:406.27192Olmesartan Medoxomil Related Compound A (1-{[2'-(1H-Tetrazol-5-yl)biphenyl-4-yl]methyl}-4,4-dimethyl-2-propyl-1H-furo[3,4-d]imidazol-6(4H)-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C24H24N6O2Cor e Forma:White SolidPeso molecular:428.19607Terazosin Related Compound C (1,4-Bis(4-amino-6,7-dimethoxy-2-quinazolinyl)piperazine, dihydrochloride)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C24H28N8O4·2HClCor e Forma:Off-White PowderPeso molecular:492.22335Glycopyrrolate Related Compound B (1-Methylpyrrolidin-3-yl 2-cyclopentyl-2-hydroxy-2-phenylacetate Hydrochloride)
CAS:Aromatic polycarboxylic acids, their anhydrides, halideFórmula:C18H25NO3Cor e Forma:Off-White PowderPeso molecular:339.86Moxifloxacin Related Compound C (1-Cyclopropyl-8-ethoxy-6-fluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride monohydrate)
Compounds (excluding drugs and pesticides) containing a quinoline or isoquinoline ringFórmula:C22H26FN3O4·HCl·H2OCor e Forma:SolidPeso molecular:415.19073N-Nitroso Diclofenac (2-(2-((2,6-dichlorophenyl) (nitroso)amino)phenyl)acetic acid)
CAS:Compounds with other nitrogen function, nesoiFórmula:C14H10Cl2N2O3Cor e Forma:Off-White PowderPeso molecular:324.00685Cyclosporine
CAS:Lactams, nesoiFórmula:C62H111N11O12Cor e Forma:White PowderPeso molecular:1201.84137Telmisartan Related Compound B (4'-[(1,7'-dimethyl-2'-propyl-1H,1'H-2,5'-bibenzo[d]imidazol-1'-yl)methyl]biphenyl-2-carboxylic acid)
CAS:Drugs with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C33H30N4O2Cor e Forma:White PowderPeso molecular:514.23688Ketorolac Related Compound A (5-Benzoyl-N-(1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)-2,3-dihydro-1H-pyrrolizine-1-carboxamide)
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFórmula:C19H22N2O5Cor e Forma:White PowderPeso molecular:358.15287Nateglinide Related Compound B (N-(trans-4-isopropylcyclohexanecarbonyl)-L-phenylalanine)
CAS:Aromatic cyclic amides (including cyclic carbamates) anFórmula:C19H27NO3Cor e Forma:White PowderPeso molecular:317.19909Acebutolol Related Compound I (N-{3-Acetyl-4-[3-(ethylamino)-2-hydroxypropoxy]phenyl}butyramide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C17H26N2O4Cor e Forma:PowderPeso molecular:322.18926Bisoctrizole Related Compound A (2-(2H-Benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl) phenol)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C20H25N3OCor e Forma:SolidPeso molecular:323.19976Azacitidine Related Compound B (1-O-Acetyl-2,3,5-tri-O-benzoyl-β-D-ribofuranose)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C28H24O9Cor e Forma:PowderPeso molecular:504.14203Benazepril Related Compound D (3-(1-Ethoxycarbonyl-3-cyclohexyl-(1S)-propyl)amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine-1-acetic acid monohydrochloride)
CAS:Lactams, nesoiFórmula:C24H34N2O5·HClCor e Forma:White Fine PowderPeso molecular:430.24677Rivaroxaban Related Compound G ((S)-2-({2-oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)isoindoline-1,3-dione)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C22H19N3O6Cor e Forma:White Off-White SolidPeso molecular:421.12739Dronedarone Related Compound D ((2-Butyl-5-nitrobenzofuran-3-yl)(4-hydroxyphenyl)methanone)
CAS:Aromatic pesticides with oxygen heteroFórmula:C19H17NO5Cor e Forma:SolidPeso molecular:339.11067Fosinopril Related Compound B ((4S)-4-Cyclohexyl-1-[(R)-[(S)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]acetyl-D-proline propionate (ester), hemibarium salt, sesquihydrate)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C30H45NO7PBaH2OCor e Forma:White PowderPeso molecular:562.29336Imiquimod Related Compound C (4-Chloro-1-isobutyl-1H-imidazo[4,5-c]quinoline)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C14H14ClN3Cor e Forma:White Crystalline PowderPeso molecular:259.08763Antipyrine Related Compound A (3-Methyl-1-phenyl-1H-pyrazol-5(4H)-one)
CAS:Aromatic or modified aromatic compounds containg an unfused pyrazolering (whether or not hydrogenated) in the structureFórmula:C10H10N2OCor e Forma:White Pale Yellow PowderPeso molecular:174.07931Zolmitriptan Related Compound E ((S)-N,N-dimethyl-2-{5-[(2-oxooxazolidin-4-yl)methyl]-1H-indol-3-yl}ethanamine oxide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C16H21N3O3Cor e Forma:Off-White PowderPeso molecular:303.15829Fluorouracil Related Compound E (5-Chloropyrimidine-2,4(1H,3H)-dione)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C4H3ClN2O2Cor e Forma:White Off-White PowderPeso molecular:145.98831Cefadroxil Related Compound D ((6R,7R)-7-[(S)-2-Amino-2-(4-hydroxyphenyl)acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid)
CAS:Aminoglycoside antibioticsFórmula:C16H17N3O5SCor e Forma:White PowderPeso molecular:363.08889Palonosetron Related Compound D ((R)-2-[(3S)-Quinuclidin-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinolin-1-one hydrochloride)
CAS:Lactams, nesoiFórmula:C19H24N2O·HClCor e Forma:White Yellow PowderPeso molecular:332.16554Allopurinol Related Compound D (Ethyl 5-amino-1H-pyrazole-4-carboxylate)
CAS:Compounds containing an unfused pyrazole ring (whether or not hydrogenated) in the structure nesoiFórmula:C6H9N3O2Cor e Forma:White Light Yellow Crystalline PowderPeso molecular:155.06948Mefloquine Related Compound A (threo-mefloquine)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C17H16F6N2O·HClCor e Forma:White PowderPeso molecular:378.11668Moexipril Related Compound D ((S)-2-{(S)-2-[(S)-4-cyclohexyl-1-ethoxy-1-oxobutan-2-ylamino]propanoyl}-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride)
CAS:Compounds containing a quinoline or isoquinoline ring-system, whether or not hydrogenated, not further fused, excluding drugs and pesticidesFórmula:C27H40N2O7·HClCor e Forma:Beige PowderPeso molecular:541.08Rivastigmine Related Compound F (3-Vinylphenyl ethyl(methyl)carbamate)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C12H15NO2Cor e Forma:Colorless LiquidPeso molecular:205.11028Bumetanide Related Compound B (3-Nitro-4-phenoxy-5-sulfamoylbenzoic Acid)
CAS:Sulfonamides, nesoiFórmula:C13H10N2O7SCor e Forma:Light Yellow PowderPeso molecular:338.02087Uracil Arabinoside
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C9H12N2O6Cor e Forma:White Off-White PowderPeso molecular:244.06954Ioversol Related Compound B (N,N'-Bis(2,3-dihydroxypropyl)-5-{[N-(2-hydroxyethyl)amino]-2-oxoethoxy}-2,4,6-triiodoisophthalamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C18H24I3N3O9Cor e Forma:White Off-White GranularPeso molecular:806.86467Azelastine Related Compound F (4-[4-(4-Chlorobenzyl)-1-oxophthalazin-2(1H)-yl]-1-methylazepane 1-oxide)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C22H24ClN3O2Cor e Forma:White SolidPeso molecular:397.1557Clopidogrel Open Ring Hydrochloride (methyl (S)-2-(2-chlorophenyl)-2-((2-(thiophen-2-yl)ethyl)amino) acetate, hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C15H16ClNO2S·HClCor e Forma:White Off-White SolidPeso molecular:345.03571Tetrahydrothienopyridine Hydrochloride (4,5,6,7-Tetrahydrothieno[3,2-c]pyridine, hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C7H9NS·HClCor e Forma:Off-White SolidPeso molecular:139.04557Paliperidone Related Compound D (4-(6-Fluorobenzo[d]isoxazol-3-yl)-1-[2-(9-hydroxy-2-methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-3-yl)ethyl]piperidine 1-oxide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C23H27FN4O4Cor e Forma:White PowderPeso molecular:442.20163Amitraz Related Compound B (N'-(2,4-Dimethylphenyl)-N-methylformimidamide)
CAS:Aromatic imines and their derivatives, salts thereofFórmula:C10H14N2Cor e Forma:PowderPeso molecular:162.1157Voriconazole Related Compound C (1-(2,4-Difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone)
Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFórmula:C10H7F2N3OCor e Forma:Pale Yellow SolidPeso molecular:223.05572Ethyl 3-Aminocrotonate (Ethyl (Z)-3-aminobut-2-enoate)
CAS:Amino-acids (excluding aromatic) and their esters other than those containing more than one kind of oxygen function, nesoiFórmula:C6H11NO2Cor e Forma:Colorless Pale Yellow Liquid At Room TemperaturePeso molecular:129.07898Cinacalcet Related Compound D ((S)-N-[1-(Naphthalen-1-yl)ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine hydrochloride)
CAS:Aromatic monoamines not elsewhere specified or included and their derivatives, salts therofFórmula:C22H22F3N·HClCor e Forma:Pale Yellow PowderPeso molecular:393.14711Methyclothiazide Related Compound A (4-Amino-6-chloro-N-3-methyl-m-benzenedisulfonamide)
Sulfonamides, nesoiFórmula:C7H10ClN3O4S2Cor e Forma:PowderPeso molecular:298.98013Valacyclovir Related Compound E (2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-benzyloxycarbonyl-L-valinate)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C21H26N6O6Cor e Forma:White Crystalline PowderPeso molecular:458.19138Vardenafil Related Compound D (2-{2-Ethoxy-5-[(4-ethyl-4-oxidopiperazin-1-yl)sulfonyl]phenyl}-5-methyl-7-propyl-imidazo[5,1-f][1,2,4]triazin-4(3H)-one)
CAS:Sulfonamides, nesoiFórmula:C23H32N6O5SCor e Forma:White PowderPeso molecular:504.21549Indomethacin Related Compound A (2-(5-methoxy-2-methyl-1H-indol-3-yl)acetic acid)
CAS:Aromatic or modified aromatic drugs with nitrogen heteroFórmula:C12H13NO3Cor e Forma:Light Yellow Crystalline PowderPeso molecular:219.08954Bisacodyl Related Compound B (2,4'-(Pyridin-2-ylmethylene)diphenol)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C18H15NO2Cor e Forma:White Light Yellow PowderPeso molecular:277.11028Eszopiclone Related Compound A (6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo [3,4,b] pyrazin-5-yl 4-methylpiperazine-1-carboxylate 4-oxide)
CAS:Lactams not elsewhere specified or includedFórmula:C17H17ClN6O4Cor e Forma:Off-White PowderPeso molecular:404.09998Zaleplon Related Compound C (7-[3-(N-ethylacetamido)phenyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C17H17N5O2Cor e Forma:PowderPeso molecular:323.13822Desflurane Related Compound A (Bis-(1,2,2,2-tetrafluoroethyl)ether)
CAS:Ethers of monohydric alcohols, nesoiFórmula:C4H2F8OCor e Forma:Colorless LiquidPeso molecular:217.99779Timolol Related Compound A ((R)-1-(tert-Butylamino)-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy)propan-2-ol maleate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C13H24N4O3S·C4H4O4Cor e Forma:White PowderPeso molecular:432.16787Decitabine Related Compound A (1-O-Acetyl-3,5-di-O-(4-chlorobenzoyl)-2-deoxy-D-ribofuranose)
CAS:Compounds containing an unfused furan ring (whether or not hydrogenated) in the structure nesoiFórmula:C21H18Cl2O7Cor e Forma:Off-White White PowderPeso molecular:452.04296Azathioprine Related Compound A (1-Methyl-4-nitro-1H-imidazol-5-amine)
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFórmula:C4H6N4O2Cor e Forma:Yellow PowderPeso molecular:142.04908Acamprosate Related Compound A (3-aminopropane-1-sulfonic acid)
CAS:Acyclic monoamines and their derivatives, nesoiFórmula:C3H9NO3SCor e Forma:PowderPeso molecular:139.03031Lumefantrine Related Compound A ((RS, Z)-2-(Dibutylamino)-2-(2,7-dichloro-9-(4-chlorobenzylidene)-9H-fluoren-4-yl)ethanol hydrochloride)
Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFórmula:C30H32Cl3NO·HClCor e Forma:Yellow PowderPeso molecular:527.15495Nicotine Related Compound D (3-(4,5-dihydro-3H-pyrrol-2-yl)pyridine fumarate)
CAS:Other alkaloids,natural or reproduced by synthesis, and their salts, ethers,esters&other derivatives, nesoiFórmula:C9H10N2Cor e Forma:White Light Brown PowderPeso molecular:146.0844Phenylbutyrate Related Compound B (3,4-dihydronaphthalen-1(2H)-one)
CAS:Aromatic ketones without other oxygen function, nesoiFórmula:C10H10OCor e Forma:Yellow LiquidPeso molecular:146.19Dexmedetomidine Related Compound A ((2,3-Dimethylphenyl)(1H-imidazol-4-yl)methanone)
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFórmula:C12H12N2OCor e Forma:White PowderPeso molecular:200.09496Temozolomide Related Compound B (3-methyl-1,1-diphenylurea)
CAS:Ureines and their derivatives; salts thereofFórmula:C14H14N2OCor e Forma:PowderPeso molecular:226.11061Fludeoxyglucose Related Compound A (4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C18H36N2O6Cor e Forma:Colorless Light Yellow Crystalline SolidPeso molecular:376.25734Allopurinol
CAS:Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFórmula:C5H4N4OCor e Forma:White PowderPeso molecular:136.03851Salicylic Acid Related Compound B (4-hydroxyisophthalic acid)
CAS:Carboxylic acids with phenol function but without other oxygen function, their anhydrides, halides, peroxides etc, nesoiFórmula:C8H6O5Cor e Forma:White SolidPeso molecular:182.02152Frovatriptan Related Compound A ((R)-3-Amino-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C13H15N3OCor e Forma:Off-White SolidPeso molecular:229.12151Fluorouracil Related Compound A (Pyrimidine-2,4,6(1H,3H,5H)-trione)
CAS:Malonylurea (barbituric acid) and its saltsFórmula:C4H4N2O3Cor e Forma:White PowderPeso molecular:128.02219Poloxamer Solid
CAS:Nonionic surface-active agents,aromatic or modified aromatic,whether or not put up for retail saleFórmula:HO(C2H4O)a(C3H6O)b(C2H4O)aHCor e Forma:White Cream PowderPeso molecular:304.2931Ribavirin Related Compound D (1H-1,2,4-triazole-3-carboxamide)
CAS:Heterocyclic compounds (excluding aromatic or modifiedFórmula:C3H4N4OCor e Forma:Pale Yellow Crystalline PowderPeso molecular:112.03851Topotecan Related Compound A ((S)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-8-methoxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione)
CAS:Other alkaloids,natural or reproduced by synthesis, and their salts, ethers,esters&other derivatives, nesoiFórmula:C24H25N3O6Cor e Forma:SolidPeso molecular:451.17434Nifedipine Nitrosophenylpyridine Analog (Dimethyl 4-(2-nitrosophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C17H16N2O5Cor e Forma:Blue-Green Crystalline PowderPeso molecular:328.10592Tizanidine Related Compound B (N-acetyltizanidine)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C11H10ClN5OSCor e Forma:Yellow PowderPeso molecular:295.02946Ketamine Related Compound A (1-[(2-Chlorophenyl)(methylimino)methyl]cylcopentanol)
CAS:Aromatic imines and their derivatives, salts thereofFórmula:C13H16NOClCor e Forma:Off-White PowderPeso molecular:237.09204Valproic Acid Related Compound K (2-Ethyl-2-methylpentanoic acid)
CAS:Saturated acyclic monocarboxylic acids and their anhydrides, halides, peroxides etc, nesoiFórmula:C8H16O2Cor e Forma:Clear Yellow Oily LiquidPeso molecular:144.11503Primidone Related Compound C (2-phenyl butyramide)
CAS:Aromatic cyclic amides (including cyclic carbamates) anFórmula:C10H13NOCor e Forma:White Crystalline PowderPeso molecular:163.09971Ethylparaben
CAS:Carboxylic acids with phenol function but without other oxygen function, their anhydrides, halides, peroxides etc, nesoiFórmula:C9H10O3Cor e Forma:White Colorless SolidPeso molecular:166.17Lomustine Related Compound D (3-(2-Chloroethyl)-1-cyclohexyl-1-nitrosourea)
CAS:Compounds with other nitrogen function, nesoiFórmula:C9H16ClN3O2Cor e Forma:Light Yellow PowderPeso molecular:233.0931Atenolol Related Compound C (2-[4-(Oxiran-2-ylmethoxy)phenyl]acetamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C11H13NO3Cor e Forma:White SolidPeso molecular:207.08954Zolmitriptan Related Compound H (4,4-Diethoxy-N,N-dimethylbutan-1-amine)
CAS:Non-aromatic amino-compounds with oxygen functionFórmula:C10H23NO2Cor e Forma:Clear Colorless LiquidPeso molecular:189.17288Carisoprodol Related Compound A (2-hydroxymethyl-2-methylpentyl carbamate)
CAS:Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFórmula:C8H17NO3Cor e Forma:White PowderPeso molecular:175.12084Ethambutol Related Compound A ((2R,2'S)-2,2'-[ethane-1,2-diylbis(azanediyl)]dibutan-1-ol)dihydrochloride)
CAS:Amino-alcohols, other than those containing more than oFórmula:C10H24N2O2Cor e Forma:White PowderPeso molecular:204.18378Roflumilast Related Compound A (3-(Cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)-4-hydroxybenzamide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C16H14Cl2N2O3Cor e Forma:Light Orange PowderPeso molecular:352.03815Tranexamic Acid Related Compound C ((RS)-4-(Aminomethyl)cyclohex-1-enecarboxylic acid hydrochloride)
CAS:Amino-acids and their esters other than those containing more than one kind of oxygen function, excluding aromatic amino-acids, nesoiFórmula:C8H13NO2·HClCor e Forma:White Off-White PowderPeso molecular:191.07131Tiagabine Related Compound A ((R)-ethyl 1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylate, hydrochloride)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C22H29NO2S2·HClCor e Forma:White PowderPeso molecular:440.07Loratadine Related Compound A (8-Chloro-5,6-dihydro-11-(piperidin-4-ylidene)-11H-benzo[5,6]cyclohepta[1,2-b]pyridine)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C19H19ClN2Cor e Forma:White Off-White Crystalline PowderPeso molecular:310.12368(R)-Clopidogrel Carboxylic Acid ((R)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C15H14ClNO2SCor e Forma:Off-White SolidPeso molecular:307.04338Iminodibenzyl (10,11-Dihydro-5H-dibenzo[b,f]azepine)
CAS:Aromatic or modified aromatic heterocyclic compounds with nitrogen hetero atom(s) only, except acridine, indole and carbazoleFórmula:C14H13NCor e Forma:White Light Yellow PowderPeso molecular:195.1048Methylprednisolone Related Compound C (11β-Hydroxy-6α-methylandrosta-1,4-diene-3,17-dione)
CAS:Adrenal cortical hormones and their derivatives nesoiFórmula:C20H26O3Cor e Forma:PowderPeso molecular:314.18819Zolmitriptan Related Compound A ((S)-4-({3-[2-(Methylamino)ethyl]-1H-indol-5-yl}methyl)oxazolidin-2-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C15H19N3O2Cor e Forma:SolidPeso molecular:273.14773Atenolol Related Compound F (2,2'-[{[(Isopropylazanediyl)bis(2-hydroxypropane-3,1-diyl)]bis(oxy)}bis(4,1-phenylene)]diacetamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C25H35N3O6Cor e Forma:White PowderPeso molecular:473.25259Methylisoindolinedione (2-methylisoindoline-1,3-dione)
CAS:Imides and their derivatives (excluding sacharin), and salts thereofFórmula:C9H7NO2Cor e Forma:White Off-White SolidPeso molecular:161.047681,3-Dichlorotetramethyldisiloxane
CAS:Fórmula:C4H12Cl2OSi2Pureza:97%Cor e Forma:LiquidPeso molecular:203.2145Butanoic acid, 2-amino-4,4,4-trifluoro-
CAS:Fórmula:C4H6F3NO2Pureza:97%Cor e Forma:SolidPeso molecular:157.09114H-1-Benzopyran-4-one,2,3-dihydro-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-, (2S)-
CAS:Fórmula:C16H14O6Pureza:97%Cor e Forma:SolidPeso molecular:302.2788Ref: IN-DA00DEG0
1g24,00€5g30,00€10g34,00€1kg586,00€25g54,00€2kgA consultar5kgA consultar100g114,00€10kg2.399,00€500g504,00€100kg19.743,00€N-Boc-aminooxyacetic acid N-hydroxysuccinimide ester
CAS:Fórmula:C11H16N2O7Pureza:95%Cor e Forma:SolidPeso molecular:288.2539Ecabet sodium pentahydrate
CAS:Fórmula:C20H37NaO10SPureza:98%Cor e Forma:SolidPeso molecular:492.55661H-Purine-2,6-dione, 3,7-dihydro-1,3-dimethyl-, compd. with1,2-ethanediamine (2:1)OTHER CA INDEX NAMES:1,2-Ethanediamine, compd. with3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione (1:2)
CAS:Fórmula:C16H24N10O4Pureza:%Cor e Forma:SolidPeso molecular:420.42645-BROMO-4'-CHLOROSALICYLANILIDE
CAS:Fórmula:C13H9BrClNO2Pureza:98%Cor e Forma:SolidPeso molecular:326.5731Ref: IN-DA003AD5
1g36,00€5g86,00€10g111,00€1kgA consultar25g176,00€2kgA consultar100g584,00€500gA consultar250mg25,00€BERBERINE SULFATE TRIHYDRATE
CAS:Fórmula:C40H36N2O12SPureza:98%Cor e Forma:SolidPeso molecular:768.7850Sodium Erythorbate Monohydrate
CAS:Fórmula:C6H9NaO7Pureza:98%Cor e Forma:SolidPeso molecular:216.12122-piperazin-1-yl-1,3-thiazole
CAS:Fórmula:C7H11N3SPureza:97%Cor e Forma:LiquidPeso molecular:169.2473Benzoic acid, 4-amino-2-chloro-
CAS:Fórmula:C7H6ClNO2Pureza:97%Cor e Forma:SolidPeso molecular:171.5810Ref: IN-DA008RA9
1g281,00€10gA consultar25gA consultar50gA consultar10mg52,00€100mg120,00€250mg157,00€2-Pyrrolidinecarbonitrile, 1-(2-chloroacetyl)-, (2S)-
CAS:Fórmula:C7H9ClN2OPureza:97%Cor e Forma:SolidPeso molecular:172.6122N-[2-(diethylamino)ethyl]-5-methanesulfonyl-2-methoxybenzamide hydrochloride
CAS:Fórmula:C15H25ClN2O4SPureza:98%Cor e Forma:SolidPeso molecular:364.8880L-Lysine, monohydrochloride
CAS:Fórmula:C6H15ClN2O2Pureza:98%Cor e Forma:SolidPeso molecular:182.6485Ref: IN-DA00IBIP
25g20,00€100g24,00€25kg619,00€500g31,00€50kgA consultar100kgA consultar250kgA consultar4,7,10,13,16,19,22,25,28-Nonaoxahentriacontanedioic acid, 1,31-bis(2,5-dioxo-1-pyrrolidinyl) ester
CAS:Fórmula:C30H48N2O17Pureza:97%Cor e Forma:LiquidPeso molecular:708.7053Butanedioic acid,mono[(3R,5aS,6R,8aS,9R,10S,12R,12aR)-decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10-yl] ester
CAS:Fórmula:C19H28O8Pureza:98%Cor e Forma:SolidPeso molecular:384.4208(2S,3R)-2-(((9-Fluorenylmethoxy)carbonyl)amino)-3-(tert-butoxy)butanoic acid
CAS:Fórmula:C23H27NO5Pureza:98%Cor e Forma:SolidPeso molecular:397.4642Boc-9-AMino-4,7-Dioxanonanoic acid
CAS:Fórmula:C14H27NO7Pureza:98%Cor e Forma:LiquidPeso molecular:321.3667Ref: IN-DA009VU1
1g54,00€5g124,00€10g173,00€25g550,00€50gA consultar100gA consultar250gA consultar100mg22,00€250mg26,00€500mg34,00€L-Lysine, N6-(aminoiminomethyl)-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-
CAS:Fórmula:C22H26N4O4Pureza:98%Cor e Forma:SolidPeso molecular:410.46622-(4-Methoxyphenyl)-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one
CAS:Fórmula:C20H20O7Pureza:95%Cor e Forma:SolidPeso molecular:372.36864-Chloro-n-imidazolidin-2-ylidene-6-methoxy-2-methylpyrimidin-5-amine
CAS:Fórmula:C9H12ClN5OPureza:98%Cor e Forma:SolidPeso molecular:241.67755-fluoro-1,2,3,4-tetrahydropyrimidine-2,4-dione
CAS:Fórmula:C4H3FN2O2Pureza:98%Cor e Forma:SolidPeso molecular:130.07722-Propynoic acid, 1,1-dimethylethyl ester
CAS:Fórmula:C7H10O2Pureza:98%Cor e Forma:LiquidPeso molecular:126.1531Ref: IN-DA0018IR
1g29,00€5g63,00€10g95,00€25g164,00€50g223,00€100g563,00€250gA consultar500gA consultar1-PHTHALAZINAMINE, N-(3-CHLOROPHENYL)-4-PHENYL-
CAS:Fórmula:C20H14ClN3Pureza:99%Cor e Forma:SolidPeso molecular:331.7983Propafenone
CAS:<p>Propafenone: a drug for ventricular arrhythmias with mild beta-blocker activity, prolongs refractory period, and reduces heart automaticity.</p>Fórmula:C21H27NO3Pureza:99.02%Cor e Forma:SolidPeso molecular:341.44Benzamide, 3-(cyclopropylmethoxy)-N-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)-
CAS:Fórmula:C17H14Cl2F2N2O3Pureza:97%Cor e Forma:SolidPeso molecular:403.20752-[2-(2-Aminoethoxy)ethoxy]ethanol
CAS:Fórmula:C6H15NO3Pureza:98%Cor e Forma:LiquidPeso molecular:149.1882Boc-L-Glutamic acid 5-benzyl ester
CAS:Fórmula:C17H23NO6Pureza:95%Cor e Forma:SolidPeso molecular:337.36765H-Cyclopenta[b]pyridinium,1-[[(6R,7R)-7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-6,7-dihydro-, sulfate (1:1)
CAS:Fórmula:C22H24N6O9S3Pureza:82%Cor e Forma:SolidPeso molecular:612.6558(Z)-3-cyano-1-methyl-2-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl)guanidine
CAS:Fórmula:C10H16N6SPureza:98%Cor e Forma:SolidPeso molecular:252.3392Dibenzo[a,c]cyclooctene,5,6,7,8-tetrahydro-1,2,3,10,11,12-hexamethoxy-6,7-dimethyl-,(6R,7S,12aR)-
CAS:Fórmula:C24H32O6Pureza:98%Cor e Forma:SolidPeso molecular:416.5073N6-Benzoyl-2'-deoxyadenosine
CAS:Fórmula:C17H17N5O4Pureza:95%Cor e Forma:SolidPeso molecular:355.3480L-Leucine, N-[(1,1-dimethylethoxy)carbonyl]-N-methyl-
CAS:Fórmula:C12H23NO4Pureza:95%Cor e Forma:SolidPeso molecular:245.3153Cyclohexaneacetic acid, α-amino-, (αR)-
CAS:Fórmula:C8H15NO2Pureza:95%Cor e Forma:SolidPeso molecular:157.2102Benzoic acid, 2-(acetyloxy)-, 4-(acetylamino)phenyl ester
CAS:Fórmula:C17H15NO5Pureza:98%Cor e Forma:SolidPeso molecular:313.3047(6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-(hydroxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
CAS:Fórmula:C14H13N5O5S2Pureza:97%Cor e Forma:SolidPeso molecular:395.41351-[(2-Propynyloxy)methyl]pyrene
CAS:Fórmula:C20H14OPureza:98%Cor e Forma:SolidPeso molecular:270.32461-benzyl-5-oxopyrrolidine-3-carboxylic acid
CAS:Fórmula:C12H13NO3Pureza:98%Cor e Forma:SolidPeso molecular:219.2365Ref: IN-DA0034Y7
1g25,00€5g25,00€10g29,00€1kg672,00€25g40,00€5kgA consultar100g92,00€10kgA consultar25kgA consultar500g250,00€[Arg8]Vasopressin TFA
CAS:Fórmula:C48H66F3N15O14S2Pureza:98%Cor e Forma:SolidPeso molecular:1198.25494-(Prop-2-yn-1-yl)thiomorpholine 1,1-dioxide
CAS:Fórmula:C7H11NO2SPureza:97%Cor e Forma:SolidPeso molecular:173.2327
![Buspirone Related Compound N (8,8'-(Butane-1,4-diyl)bis(8-azaspiro[4.5]decane-7,9-dione)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1078835.webp&w=3840&q=75)
![Loratadine Related Compound C (8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1370269.webp&w=3840&q=75)
![Perphenazine Related Compound B (2-{4-[3-(10H-phenothiazin-10-yl)propyl]piperazin-1-yl}ethanol)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1511021.webp&w=3840&q=75)
![Milnacipran Related Compound C ((1RS ,2SR)-2-[(1,3-Dioxoisoindolin-2-yl)methyl]-N,N-diethyl-1-phen…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1443680.webp&w=3840&q=75)
![Zolmitriptan Related Compound E ((S)-N,N-dimethyl-2-{5-[(2-oxooxazolidin-4-yl)methyl]-1H-indol-3-y…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1727064.webp&w=3840&q=75)
![Cefadroxil Related Compound D ((6R,7R)-7-[(S)-2-Amino-2-(4-hydroxyphenyl)acetamido]-3-methyl-8-oxo…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1097148.webp&w=3840&q=75)
![Valacyclovir Related Compound E (2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-benzy…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1707872.webp&w=3840&q=75)
![N-[2-(diethylamino)ethyl]-5-methanesulfonyl-2-methoxybenzamide hydrochloride](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA00IML5.webp&w=3840&q=75)
![L-Lysine, N6-(aminoiminomethyl)-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA00ICVD.webp&w=3840&q=75)
![2-[2-(2-Aminoethoxy)ethoxy]ethanol](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA0038KP.webp&w=3840&q=75)
![5H-Cyclopenta[b]pyridinium,1-[[(6R,7R)-7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-2…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA00IK5Y.webp&w=3840&q=75)
![(Z)-3-cyano-1-methyl-2-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl)guanidine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA00I97O.webp&w=3840&q=75)
![Dibenzo[a,c]cyclooctene,5,6,7,8-tetrahydro-1,2,3,10,11,12-hexamethoxy-6,7-dimethyl-,(6R,7S,12aR)-](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA00IATX.webp&w=3840&q=75)
![L-Leucine, N-[(1,1-dimethylethoxy)carbonyl]-N-methyl-](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA00I9J2.webp&w=3840&q=75)
![(6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-(hydroxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-az…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA00IGWE.webp&w=3840&q=75)
![[Arg8]Vasopressin TFA](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA000TUQ.webp&w=3840&q=75)
